146 related articles for article (PubMed ID: 28881745)
1. Whole tumor RNA-sequencing and deconvolution reveal a clinically-prognostic PTEN/PI3K-regulated glioma transcriptional signature.
Pan Y; Bush EC; Toonen JA; Ma Y; Solga AC; Sims PA; Gutmann DH
Oncotarget; 2017 Aug; 8(32):52474-52487. PubMed ID: 28881745
[TBL] [Abstract][Full Text] [Related]
2. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.
Solga AC; Pong WW; Kim KY; Cimino PJ; Toonen JA; Walker J; Wylie T; Magrini V; Griffith M; Griffith OL; Ly A; Ellisman MH; Mardis ER; Gutmann DH
Neoplasia; 2015 Oct; 17(10):776-88. PubMed ID: 26585233
[TBL] [Abstract][Full Text] [Related]
3. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.
Guo X; Pan Y; Gutmann DH
Neuro Oncol; 2019 Oct; 21(10):1250-1262. PubMed ID: 31111915
[TBL] [Abstract][Full Text] [Related]
4. Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation.
de Andrade Costa A; Chatterjee J; Cobb O; Cordell E; Chao A; Schaeffer S; Goldstein A; Dahiya S; Gutmann DH
Neurooncol Adv; 2022; 4(1):vdab194. PubMed ID: 35187488
[TBL] [Abstract][Full Text] [Related]
5. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
[TBL] [Abstract][Full Text] [Related]
6. RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.
De Andrade Costa A; Chatterjee J; Cobb O; Sanapala S; Scheaffer S; Guo X; Dahiya S; Gutmann DH
Neuro Oncol; 2022 Jan; 24(1):14-26. PubMed ID: 34043012
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
Daginakatte GC; Gutmann DH
Hum Mol Genet; 2007 May; 16(9):1098-112. PubMed ID: 17400655
[TBL] [Abstract][Full Text] [Related]
8. Increased Tissue Stiffness in Tumors from Mice with Neurofibromatosis-1 Optic Glioma.
Walter C; Crawford L; Lai M; Toonen JA; Pan Y; Sakiyama-Elbert S; Gutmann DH; Pathak A
Biophys J; 2017 Apr; 112(8):1535-1538. PubMed ID: 28445745
[TBL] [Abstract][Full Text] [Related]
9. The Sociobiology of Brain Tumors.
Gutmann DH
Adv Exp Med Biol; 2020; 1225():115-125. PubMed ID: 32030651
[TBL] [Abstract][Full Text] [Related]
10. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.
Hegedus B; Banerjee D; Yeh TH; Rothermich S; Perry A; Rubin JB; Garbow JR; Gutmann DH
Cancer Res; 2008 Mar; 68(5):1520-8. PubMed ID: 18316617
[TBL] [Abstract][Full Text] [Related]
11. Improving outcomes for neurofibromatosis 1-associated brain tumors.
Brossier NM; Gutmann DH
Expert Rev Anticancer Ther; 2015 Apr; 15(4):415-23. PubMed ID: 25652347
[TBL] [Abstract][Full Text] [Related]
12. Midkine activation of CD8
Guo X; Pan Y; Xiong M; Sanapala S; Anastasaki C; Cobb O; Dahiya S; Gutmann DH
Nat Commun; 2020 May; 11(1):2177. PubMed ID: 32358581
[TBL] [Abstract][Full Text] [Related]
13. The molecular and cell biology of pediatric low-grade gliomas.
Chen YH; Gutmann DH
Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
[TBL] [Abstract][Full Text] [Related]
14. The role of microglia and macrophages in glioma maintenance and progression.
Hambardzumyan D; Gutmann DH; Kettenmann H
Nat Neurosci; 2016 Jan; 19(1):20-7. PubMed ID: 26713745
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
16. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
17. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
19. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
20. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH
Ann Neurol; 2005 Jan; 57(1):119-27. PubMed ID: 15622533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
